Posted:
11/27/2024, 11:49:08 PM
Location(s):
Somerville, Massachusetts, United States ⋅ Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
AI & Machine Learning
About Generate:Biomedicines
Generate:Biomedicines is a new kind of therapeutics company – existing at the intersection of machine learning, biological engineering, and medicine – pioneering Generative Biology™ to create breakthrough medicines where novel therapeutics are computationally generated, instead of being discovered. The Company has built a machine learning-powered biomedicines platform with the potential to generate new drugs across a wide range of biologic modalities. This platform represents a potentially fundamental shift in what is possible in the field of biotherapeutic development.
We pursue this audacious vision because we believe in the unique and revolutionary power of generative biology to radically transform the lives of billions, with an outsized opportunity for patients in need. We are seeking collaborative, relentless problem solvers that share our passion for impact to join us!
Generate:Biomedicines was founded in 2018 by Flagship Pioneering and has received nearly $700 million in funding, providing the resources to rapidly scale the organization. The Company has offices in Somerville and Andover, Massachusetts with over 300 employees.
The Role:
Generate is seeking a highly creative and technologically curious Principal Scientist to be part of the CFPS (cell-free protein synthesis) group in our Innovation and Data Generation at Scale (IDGS) department. We believe innovations at the intersection of machine learning, computational protein design, and HTP experimentation will transform the way we bring new therapies to patients. They will contribute to efforts to expand our intrinsically scalable CFPS technology platform using synthetic biology, ML-guided optimization, and strain engineering to expand our intrinsically scalable CFPS technology platform, with the aim of increasing throughput, and dramatically shortening design-build-test cycles of novel biologics in the pre-IND pipeline. They will work to (1) further integrate CFPS technology into our HTP screening workflows at the intersection of synthetic biology, microfluidics, automation, and machine learning, 2) optimize and expand our CFPS workflows across modalities, and 3) work closely with our production scientists to design and implement productionized workflows.
The successful candidate has a proven track record of cross-disciplinary quantitative research, combining deep understanding of synthetic biology and high-throughput experimentation. Close collaboration with members from Generate’s Protein Sciences, Therapeutic Area Research, Computational, and Machine Learning teams will be crucial to produce game-changing novel CFPS workflows. This is an opportunity to perform highly innovative technology development, while being part of a collaborative and premier scientific environment in a well-funded biotech startup.
Here's how you will contribute:
The Ideal Candidate will have:
Who Will Love This Job:
#LI-RT1
Generate:Biomedicines is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
COVID Safety:
Generate:Biomedicines enforces a mandatory vaccination policy for COVID-19. All employees must be fully vaccinated and have received a booster. The purpose of this policy is to safeguard the health of our employees, their families, and the community at large from infectious disease that may be reduced by vaccinations. The Company will make exceptions to this policy if required by applicable law and will consider requests for an exemption from this policy due to a medical reason, or because of a sincerely held religious belief, or any other exemptions that may be recognized by applicable.
Recruitment & Staffing Agencies: Generate:Biomedicines does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Generate:Biomedicines or its employees is strictly prohibited unless contacted directly by the Company’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Generate:Biomedicines and the Company will not owe any referral or other fees with respect thereto.
#LI-RT1
Website: https://generatebiomedicines.com/
Headquarter Location: Somerville, Massachusetts, United States
Employee Count: 251-500
Year Founded: 2018
IPO Status: Private
Last Funding Type: Series C
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Product Research